4 registered trials, newest registry update first. Showing only trials linked to Brenipatide.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A Study of LY3537031 in Overweight, Obese, and Healthy Participants NCT06606106 | Brenipatide | Phase 1 | Active not recruiting | Eli Lilly and Company | 302 | Nov 2026 | Sep 30, 2026 |
| A Study of Brenipatide in Participants With Alcohol Use Disorder NCT07219953 | Brenipatide | Phase 3 | Recruiting | Eli Lilly and Company | 1,100 | Apr 2028 | Sep 22, 2026 |
| A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder NCT07219966 | Brenipatide | Phase 3 | Recruiting | Eli Lilly and Company | 1,100 | Apr 2028 | Sep 22, 2026 |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder NCT07412756 | Brenipatide | Phase 3 | Recruiting | Eli Lilly and Company | 1,000 | Feb 2028 | Aug 6, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
